Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Features include always present findings: Short nose, Microtia, Intellectual disability, and Wide nasal bridge and others; and common findings: Short columella, Hypoplasia of the zygomatic bone, Macrocephaly, and Aganglionic megacolon and others. 41 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 9 | Seizure, Brain atrophy, Hydrocephalus |
Biomarker and diagnostic research for chromosome 4Q32.1-q32.2 triplication syndrome has been reported in the published literature.
Phenotype severity distribution: 6 always present features, 7 common features.
No clinical trials have been registered for chromosome 4Q32.1-q32.2 triplication syndrome.
43 publications have been identified in PubMed for chromosome 4Q32.1-q32.2 triplication syndrome. Research spans Basic Science / Preclinical (60%), Review / Meta-Analysis (16%), and Case Report / Case Series (12%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 26 | 60% |
Data assembled from 4 of 12 sources · Last updated Sep 19, 2026, 2:56 PM UTC
Online Mendelian Inheritance in Man
Common questions about chromosome 4Q32.1-q32.2 triplication syndrome
Head and neck |
4 |
Macrocephaly, Microcephaly, Long face |
Muscles | 2 | Brain atrophy, Myopathic facies |
Bones and joints | 1 | Hypoplasia of the zygomatic bone |
Digestive system | 1 | Constipation |
Arms and legs | 1 | Tapered finger |
Eyes | 1 | Ptosis |
Research summaries
7 |
16% |
Patient case studies | 5 | 12% |
Testing and diagnosis research | 3 | 7% |
Disease patterns and progression | 1 | 2% |
New treatment approaches | 1 | 2% |
Chen F (2026). [PMID: 41648536](https://pubmed.ncbi.nlm.nih.gov/41648536/). *bioRxiv*. [Basic Science / Preclinical]
Lian G (2026). [PMID: 41973928](https://pubmed.ncbi.nlm.nih.gov/41973928/). *Proceedings of the National Academy of Sciences of the United States of America*. [Gene Therapy / Novel Therapeutics]
Hersch GG (2026). [PMID: 41878379](https://pubmed.ncbi.nlm.nih.gov/41878379/). *Neurol Open Access*. [Case Report / Case Series]
Baniowska MR (2026). [PMID: 42168793](https://pubmed.ncbi.nlm.nih.gov/42168793/). *Alzheimers Dement*. [Basic Science / Preclinical]
Sloan K (2026). [PMID: 41788027](https://pubmed.ncbi.nlm.nih.gov/41788027/). *G3 (Bethesda)*. [Basic Science / Preclinical]
Chen X (2026). [PMID: 41620652](https://pubmed.ncbi.nlm.nih.gov/41620652/). *BMC Mol Cell Biol*. [Basic Science / Preclinical]
Shao LR (2025). [PMID: 41110284](https://pubmed.ncbi.nlm.nih.gov/41110284/). *Epilepsy research*. [Basic Science / Preclinical]
Agrawal M (2025). [PMID: 40766504](https://pubmed.ncbi.nlm.nih.gov/40766504/). *bioRxiv : the preprint server for biology*. [Review / Meta-Analysis]
Wagemann O (2025). [PMID: 40110647](https://pubmed.ncbi.nlm.nih.gov/40110647/). *Alzheimer's & dementia : the journal of the Alzheimer's Association*. [Diagnostic / Biomarker]
Adamo M (2025). [PMID: 40190351](https://pubmed.ncbi.nlm.nih.gov/40190351/). *Brain communications*. [Basic Science / Preclinical]